VIRUS-LIKE PARTICLES (VLP) VACCINE FOR PREVENTION OF COVID-19 FOR INTRANASAL USE
	GREBENNIKOVA T V; KONDRATEVA V M; CHERNORYZH I I; ELISEEVA O V; LATYSHEV O E; SAVOCHKINA T E; LEBEDEVA V V; PLOTNIKOV A A; TSIBEZOV V; CHEREPUSHKIN S A; FILATOV I E; LARICHEV V F; FEDYAKINA I T; NORKINA S N; KOSTINA L V; ZAIKOVA O N; KHAMETOVA K M; BALANDINA M V; ELENA M P; LESNOVA E I; IURLOV K I; AKANINA D S; KOZLOVA A A; BARANETS M S; LOSICH M A; MELNICHENKO A V; GINTSBURG A L
	2024-04-27
专利权人	FEDERAL STATE BUDGETARY INST (FSBI-C)
申请日期	2024-04-27
专利号	RU2828323-C1
成果简介	NOVELTY - Group of inventions relates to biotechnology, immunology and virology. What is described is an intranasal vaccine based on virus-like particles consisting of a mixture of virus-like particles and a pharmaceutically acceptable buffer. Virus-like particles consist of four structural proteins S, M, N, E SARS-CoV-2, where S protein is selected from versions 19A, Alpha, Delta, Omicron SARS-CoV-2. A method for preventing COVID-19 has also been developed, involving intranasal introduction of the vaccine three times with an interval between injections of 21 days. USE - Biotechnology. ADVANTAGE - Group of inventions provides creating an intranasal vaccine having immunogenicity sufficient to generate an immune response against COVID-19, ability to induce humoral and cellular immune response, stimulate protective immunity of mucous membranes, as well as having an additional advantage of ease of administration compared to injectable forms. 4 cl, 3 dwg, 8 tbl, 8 ex
IPC 分类号	A61K-039/215
国家	俄罗斯
专业领域	生物科学
语种	英语
成果类型	专利
文献类型	科技成果
条目标识符	http://119.78.100.226:8889/handle/3KE4DYBR/16952
专题	中国科学院新疆生态与地理研究所
作者单位	FEDERAL STATE BUDGETARY INST (FSBI-C)
推荐引用方式 GB/T 7714	GREBENNIKOVA T V,KONDRATEVA V M,CHERNORYZH I I,et al. VIRUS-LIKE PARTICLES (VLP) VACCINE FOR PREVENTION OF COVID-19 FOR INTRANASAL USE. RU2828323-C1[P]. 2024.

条目包含的文件
条目无相关文件。

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。